SEC Form 13F
| Report period | 2025-12-31 |
|---|---|
| Publicly available | 2026-02-18 |
| Reported value | $30,189 |
| Positions | 2 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ASPIRE BIOPHARMA HLDGS INC | Unresolved | COM | $26,762 | 202,897 |
| ASPIRE BIOPHARMA HLDGS INC | ASBPW | *W EXP 02/14/203 | $3,427 | 207,693 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.